E Glorieus

818 total citations
12 papers, 617 citations indexed

About

E Glorieus is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, E Glorieus has authored 12 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in E Glorieus's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (4 papers). E Glorieus is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (5 papers) and Eosinophilic Esophagitis (4 papers). E Glorieus collaborates with scholars based in Belgium, United States and Spain. E Glorieus's co-authors include Martine De Vos, Liesbet Van Praet, Filip Van den Bosch, Dirk Elewaut, Heleen Cypers, Roos Colman, Philippe Carron, Lennart Jans, Peggy Jacques and Claude Cuvelier and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology and Journal of Crohn s and Colitis.

In The Last Decade

E Glorieus

11 papers receiving 606 citations

Peers

E Glorieus
Comparison fields: 5 of 61
  • Rheumatology 379
  • Immunology 235
  • Genetics 228
  • Molecular Biology 175
  • Epidemiology 144
Replace Liesbet Van Praet with:
Liesbet Van Praet Belgium
Gaëlle Varkas Belgium
S Laitko Germany
C. Fendler Germany
I. M. de Kleer Netherlands
Zave Chad Canada
J Dehais France
Miika Arvonen Finland
William J. Tremaine United States
Lior Yahav Israel
Liesbet Van Praet Belgium View profile →
Citations per field, relative to E Glorieus
E Glorieus · 1×
Citations per year, relative to E Glorieus
E Glorieus · 1×

Countries citing papers authored by E Glorieus

Since Specialization
Citations

This map shows the geographic impact of E Glorieus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Glorieus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Glorieus more than expected).

Fields of papers citing papers by E Glorieus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Glorieus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Glorieus. The network helps show where E Glorieus may publish in the future.

Co-authorship network of co-authors of E Glorieus

This figure shows the co-authorship network connecting the top 25 collaborators of E Glorieus. A scholar is included among the top collaborators of E Glorieus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Glorieus. E Glorieus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 1
2 1
3 2
4 0
5 1
6 3
7 1
8
Efficacy of Ustekinumab intensification and re-induction in Crohn’s disease patients with insufficient or loss of response
2
9 210
10 110
11 199
12 87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026